An honest comparison
Mounjaro / Zepbound (Tirzepatide) vs Phentermine
Mounjaro / Zepbound (Tirzepatide) and Phentermine both target weight loss and metabolic health — but through different mechanisms, with different evidence bases, and for different populations. The honest comparison favours one over the other only for specific reader profiles; for many adults, the right answer is "neither, here's what fits."
At a glance
| Metric | Mounjaro / Zepbound (Tirzepatide) | Phentermine |
|---|---|---|
| Sustainability | 6/10 | 3/10 |
| Short-term effect | 10/10 | 6/10 |
| Long-term effect | 7/10 | 4/10 |
| Cost / month | ~$1100 | ~$30 |
| Visible results | ~28 days | ~14 days |
| Evidence quality | strong | moderate |
Who should pick Mounjaro / Zepbound (Tirzepatide)
Mounjaro / Zepbound (Tirzepatide) fits adults who same population as semaglutide — bmi ≥30 with comorbidity, willing to commit to long-term treatment plus serious lifestyle protocol.
Who should pick Phentermine
Phentermine fits adults who adults with moderate obesity who can't access glp-1 drugs (cost, supply, insurance), as a short-term boost.
The honest verdict
Mounjaro / Zepbound (Tirzepatide) scores 6/10 on sustainability and 7/10 long-term, with strong evidence. Phentermine scores 3/10 sustainability and 4/10 long-term, with moderate evidence. Mounjaro / Zepbound (Tirzepatide) edges ahead long-term in our reading. The choice should be driven by which one you can actually sustain.
Why both might fail you (and what to do instead)
Both can fail when the underlying drivers (sleep, stress, ultra-processed-food saturation, metabolic adaptation in repeat dieters) aren't addressed. If you've already tried both or one and bounced, the issue isn't macros — it's protocol fit. The Metabolic Damage Assessment maps your profile to a starter protocol that addresses the actual gap.
Free · 2 minutes
Still not sure which fits?
The Metabolic Damage Assessment maps your profile to a starter protocol matched to your specific patterns — not a generic comparison.